The emergence of the BA.2.86 Omicron subvariant, commonly known as "Pirola," has sparked concerns due to its high mutation count in comparison to the dominant XBB.1.5 variant. However, recent data offers a more reassuring...
Covid-19 vaccine manufacturer Moderna is suing competitors Pfizer and BioNTech for allegedly copying its technology in making their vaccine.
Gennova Biopharmaceuticals is awaiting approval of its Gemcovac-19 vaccine for restricted emergency use in adults.
Vaccine-maker Moderna said that mRNA vaccines could be available for 'all sorts of disease areas' in five years. Other companies like Pfizer and BioNTech are also working on cancer vaccines.
13.6 million doses of the Oxford-AstraZeneca COVID-19 vaccine will be thrown out by Canada because it couldn't find any takers for it either at home or abroad.
Oxfam Group's new report released in Davos that with the cost of essential goods rising, billionaires in the food and energy sectors are increasing their fortunes by USD one billion every two days
Eminent British-Indian Cardiologist Dr Aseem Malhotra said there have already been international calls to suspend mRNA vaccines like those manufactured by Pfizer and Moderna because of the serious adverse effects especially...
The Centre for Cellular and Molecular Biology announced development of an indigenous mRNA Covid-19 vaccine candidate.
CDC officials said that they were reacting to research showing that the longer interval can provide more enduring protection against the coronavirus.
These data come from adults who were fully vaccinated, but not yet boosted.
The two-dose vaccine uses adenoviruses that infect chimpanzees to carry the gene responsible for the spike protein of the novel coronavirus.
Observing that there have been nine confirmed deaths in the US after Johnson and Johnson Covid-19 vaccine shots, the US' Center for Disease Control and...
Amid a new wave of infections, US health regulators have approved access to booster shots for all adults using either BioNTech-Pfizer or Moderna vaccines.
Amid a new wave of infections, US health regulators have approved access to booster shots for all adults using either BioNTech-Pfizer or Moderna vaccines.
The announcement has come as a great relief to the millions of Indians including—students, professionals and businessmen jabbed with Covaxin who intend to...
Moderna is prepared to deliver the first 15 million doses by the end of this year, with 35 million in the first quarter of 2022 and up to 60 million in the...
U.S. officials stress that the priority is to get shots to the 66 million unvaccinated Americans who are eligible for immunization -- those most at risk as the...
The plan, as outlined by the director of the Centers for Disease Control and Prevention and other top authorities, calls for an extra dose eight months after...
.jpg)
The action is expected for the Pfizer shot in the coming weeks. However, the Food and Drug Administration is yet to formally approve the vaccine.
_(2).jpg)
Foreign Affairs Secretary Marcelo Ebrard said the U.S. government will send AstraZeneca and Moderna vaccines, though the latter hasn't yet been approved by...
.jpg)
With “the rising force of infection” from Delta variant and eventual waning immunity, a “booster will likely be necessary to keep us as safe as...
.jpg)
The surge in infections in U.S is largely due to the highly contagious delta variant of the coronavirus, which has spread rapidly, particularly among...
The EU drug regulator said research in more than 3,700 children aged 12 to 17 showed that the Moderna Covid-19 vaccine produced a comparable antibody...
The EU drug regulator said research in more than 3,700 children aged 12 to 17 showed that the Moderna Covid-19 vaccine produced a comparable antibody...
It was the second shipment to Sri Lanka from the global COVAX effort after an AstraZeneca delivery in March.
